Cargando…
Biologics and Small Molecule Inhibitors for Treating Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis
Background: The treatment guidelines for hidradenitis suppurativa (HS) vary among different countries, and several biologics and small molecule inhibitors have been tested for treating moderate-to-severe HS over the past few years. However, treatment guidelines for HS vary among different countries....
Autores principales: | Huang, Chun-Hsien, Huang, I-Hsin, Tai, Cheng-Chen, Chi, Ching-Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220298/ https://www.ncbi.nlm.nih.gov/pubmed/35740325 http://dx.doi.org/10.3390/biomedicines10061303 |
Ejemplares similares
-
Efficacy and Safety of Biologics and Small Molecules for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis
por: Tsai, Ya-Chu, et al.
Publicado: (2023) -
Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa
por: Aarts, Pim, et al.
Publicado: (2021) -
Histopathology of Hidradenitis Suppurativa: A Systematic Review
por: Smith, Shane David Basil, et al.
Publicado: (2022) -
Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review
por: Ruggiero, Angelo, et al.
Publicado: (2022) -
Certolizumab to treat hidradenitis suppurativa
por: Shadid, Asem, et al.
Publicado: (2022)